CPHI vs EFX · rev $4.1M vs P/E 54, rev $5.68B
China Pharma Holdings Inc (CPHI) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
CPHI currently screens at market cap $29.0M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the CPHI and EFX stock pages for the full models.
Not investment advice.